ELVN Enliven Therapeutics, Inc.
Fundamentals / CIK 0001672619 / USDEnliven Therapeutics, Inc. reported $897.2M in total assets and a net loss of $113.5M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ELVN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$135.4M Operating profit
-
Net Income FY 2025-$113.5M GAAP bottom line
-
Diluted EPS FY 2025-$1.46 Split-adjusted
-
Free Cash Flow FY 2025-$66.41M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$884.4M Total debt: $1.31M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Research & Development | $85.86M | $80.78M | $64.57M | $31.02M | $38.44M | $32.15M | $19.01M |
| Total Operating Expenses | $119.7M | $104.6M | $83.53M | $38.79M | $51.44M | $41.70M | $24.12M |
| Operating Income | -$119.7M | -$104.6M | -$83.53M | -$38.79M | -$51.44M | -$41.70M | -$24.12M |
| EBITDA | -$119.4M | -$104.3M | -$83.23M | -$38.59M | -$51.34M | -$41.60M | -$24.08M |
| Income Before Tax | -- | -- | -- | $1.58M | -$51.38M | -- | -- |
| Income Tax Expense | $0 | $232K | $0 | $0 | -- | -- | -- |
| Net Income | -$103.7M | -$89.02M | -$71.58M | -$37.66M | -$51.38M | -$41.36M | -$23.46M |
| Basic EPS | -$1.83 | -$1.89 | -$2.01 | -$12.05 | -$20.29 | -$30.22 | -$285.96 |
| Diluted EPS | -$1.83 | -$1.89 | -$2.01 | -$12.05 | -$20.29 | -$30.22 | -$285.96 |
| Basic Shares Outstanding | 56.7M | 47.1M | 35.5M | 3.1M | 2.5M | 1.6M | 82.0K |
| Diluted Shares Outstanding | 56.7M | 47.1M | 35.5M | 3.1M | 2.5M | 1.6M | 82.0K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $28.02M | $29.00M | $20.69M | $21.25M | $18.23M | $21.49M | $24.89M | $20.72M |
| Total Operating Expenses | $36.05M | $37.21M | $27.82M | $34.28M | $25.10M | $28.58M | $31.69M | $26.90M |
| Operating Income | -$36.05M | -$37.21M | -$27.82M | -$34.28M | -$25.10M | -$28.58M | -$31.69M | -$26.90M |
| EBITDA | -$36.03M | -$37.20M | -$27.81M | -$34.20M | -$25.03M | -$28.50M | -$31.62M | -$26.83M |
| Income Tax Expense | -- | -- | -- | -- | $0 | $0 | -- | -- |
| Net Income | -$27.70M | -$32.48M | -$23.63M | -$29.67M | -$20.15M | -$25.34M | -$28.54M | -$23.18M |
| Basic EPS | -$0.36 | -$0.49 | -$0.38 | -- | -$0.32 | -$0.49 | -$0.57 | -- |
| Diluted EPS | -$0.36 | -$0.49 | -$0.38 | -- | -$0.32 | -$0.49 | -$0.57 | -- |
| Basic Shares Outstanding | 78.0M | 66.2M | 62.8M | -- | 62.1M | 52.1M | 50.1M | -- |
| Diluted Shares Outstanding | 78.0M | 66.2M | 62.8M | -- | 62.1M | 52.1M | 50.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $98.90M | $124.1M | $100.1M | $75.54M | $48.31M | $47.70M | $4.94M |
| Short-Term Investments | $363.7M | $189.3M | $153.0M | $0 | $41.97M | $40.52M | $23.97M |
| Cash & Short-Term Investments | $462.6M | $313.4M | $253.1M | $75.54M | $90.30M | $88.20M | $28.91M |
| Total Current Assets | $474.9M | $318.1M | $266.2M | $77.75M | $92.70M | $90.41M | $30.62M |
| Property, Plant & Equipment, Net | $34K | $458K | $742K | $890K | $250K | $349K | $442K |
| Long-Term Investments | -- | -- | -- | $0 | -- | -- | -- |
| Other Non-Current Assets | $656K | $7.17M | $4.09M | $0 | $175K | $88K | $2.23M |
| Total Non-Current Assets | $1.29M | $7.63M | $5.72M | $5.54M | $950K | $437K | $2.67M |
| Total Assets | $476.2M | $325.8M | $271.9M | $83.30M | $93.65M | $90.84M | $33.30M |
| Accounts Payable | $2.16M | $1.34M | $532K | $3.44M | $2.36M | $1.97M | $1.66M |
| Total Current Liabilities | $16.57M | $15.91M | $25.89M | $9.71M | $7.21M | $6.25M | $4.20M |
| Other Non-Current Liabilities | $0 | $0 | $67K | $659K | -- | -- | -- |
| Total Non-Current Liabilities | $0 | $0 | $67K | $659K | $406K | $160K | $184K |
| Total Liabilities | $16.57M | $15.91M | $25.96M | $10.37M | $7.62M | $6.41M | $4.38M |
| Total Debt (incl. Leases) | $399K | -- | $335K | -- | $652K | -- | -- |
| Common Stock | $59K | $49K | $41K | $1.0K | $27K | $18K | $1.0K |
| Retained Earnings | -$347.2M | -$243.5M | -$154.4M | -$82.86M | -$147.5M | -$96.11M | -$54.75M |
| Accumulated Other Comp. Income | $334K | $55K | $141K | $0 | -$16K | $4.0K | $32K |
| Total Stockholders' Equity | $459.6M | $309.8M | $245.9M | -$76.83M | -$42.89M | $84.44M | -$48.85M |
| Total Equity | $459.6M | $309.8M | $245.9M | -$76.83M | -$42.89M | $84.44M | -$48.85M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $151.7M | $135.5M | $132.2M | $98.90M | $101.7M | $119.4M | $101.7M | $124.1M |
| Short-Term Investments | $732.7M | $759.6M | $320.2M | $363.7M | $375.8M | $371.1M | $187.8M | $189.3M |
| Cash & Short-Term Investments | $884.4M | $895.2M | $452.4M | $462.6M | $477.6M | $490.5M | $289.6M | $313.4M |
| Total Current Assets | $894.8M | $907.3M | $463.1M | $474.9M | $482.7M | $495.6M | $294.3M | $318.1M |
| Property, Plant & Equipment, Net | $201K | $140K | $20K | $34K | $399K | $462K | $404K | $458K |
| Other Non-Current Assets | $962K | $1.24M | $1.19M | $656K | $7.10M | $7.24M | $7.20M | $7.17M |
| Total Non-Current Assets | $2.47M | $2.88M | $1.72M | $1.29M | $8.19M | $8.27M | $8.25M | $7.63M |
| Total Assets | $897.2M | $910.2M | $464.9M | $476.2M | $490.9M | $503.9M | $302.6M | $325.8M |
| Accounts Payable | $2.73M | $371K | $1.64M | $2.16M | $1.43M | $2.35M | $1.56M | $1.34M |
| Total Current Liabilities | $19.47M | $14.16M | $11.49M | $16.57M | $14.65M | $15.21M | $13.97M | $15.91M |
| Other Non-Current Liabilities | $805K | $913K | -- | $0 | $103K | $204K | $302K | $0 |
| Total Non-Current Liabilities | $805K | $913K | $0 | $0 | $103K | $204K | $302K | $0 |
| Total Liabilities | $20.28M | $15.07M | $11.49M | $16.57M | $14.75M | $15.41M | $14.27M | $15.91M |
| Total Debt (incl. Leases) | $1.31M | $1.51M | $302K | $399K | $490K | $580K | $667K | -- |
| Common Stock | $74K | $73K | $61K | $59K | $59K | $59K | $49K | $49K |
| Retained Earnings | -$431.0M | -$403.3M | -$370.8M | -$347.2M | -$317.5M | -$297.4M | -$272.0M | -$243.5M |
| Accumulated Other Comp. Income | -$3.51M | -$1.91M | -$382K | $334K | $221K | -$177K | -$16K | $55K |
| Total Stockholders' Equity | $876.9M | $895.1M | $453.4M | $459.6M | $476.1M | $488.5M | $288.3M | $309.8M |
| Total Equity | $876.9M | $895.1M | $453.4M | $459.6M | $476.1M | $488.5M | $288.3M | $309.8M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$103.7M | -$89.02M | -$71.58M | -$37.66M | -$51.38M | -$41.36M | -$23.46M |
| Depreciation & Amortization | $300K | $300K | $300K | $200K | $99K | $97K | $33K |
| Stock-Based Compensation | $34.02M | $20.17M | $12.91M | $3.19M | $3.85M | $2.23M | $899K |
| Change in Payables | $817K | $810K | -$2.25M | $411K | $389K | $313K | $750K |
| Operating Cash Flow | -$70.30M | -$73.19M | -$61.27M | -$32.08M | -$46.77M | -$37.40M | -$21.88M |
| Capital Expenditure | -$158K | -$44K | -$149K | -$612K | -$12K | -$18K | -$140K |
| Free Cash Flow | -$70.46M | -$73.24M | -$61.42M | -$32.69M | -$46.78M | -$37.42M | -$22.02M |
| Purchases of Investments | -$446.8M | -$350.7M | -$268.3M | $0 | -- | -- | -- |
| Investing Cash Flow | -$173.8M | -$36.00M | -$148.4M | -$612K | -$1.63M | -$16.72M | -$24.06M |
| Common Stock Issued | -- | $0 | $161.4M | $0 | -- | -- | -- |
| Financing Cash Flow | $218.9M | $133.2M | $234.3M | -$1.80M | $49.10M | $96.88M | $43.58M |
| Net Change in Cash | -$25.27M | $23.98M | $24.61M | -$34.49M | $698K | $42.76M | -$2.36M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$27.70M | -$32.48M | -$23.63M | -$29.67M | -$20.15M | -$25.34M | -$28.54M | -$23.18M |
| Depreciation & Amortization | $13K | $7.0K | $14K | $83K | $62K | $81K | $74K | $63K |
| Stock-Based Compensation | $8.06M | $13.91M | $7.40M | $12.31M | $7.18M | $7.72M | $6.80M | $5.34M |
| Change in Payables | $2.59M | -$1.50M | -$519K | $828K | -$1.02M | $789K | $220K | $323K |
| Operating Cash Flow | -$12.55M | -$18.53M | -$19.29M | -$15.84M | -$13.28M | -$17.06M | -$24.13M | -$17.20M |
| Capital Expenditure | -$94K | -$99K | $0 | $0 | $1.0K | -$139K | -$20K | $0 |
| Free Cash Flow | -$12.65M | -$18.63M | -$19.29M | -$15.84M | -$13.28M | -$17.20M | -$24.15M | -$17.20M |
| Purchases of Investments | -$45.97M | -$560.2M | -$65.84M | -$75.52M | -$71.86M | -$240.2M | -$59.23M | -$116.5M |
| Investing Cash Flow | $26.33M | -$441.6M | $42.53M | $12.38M | -$4.06M | -$183.6M | $1.43M | $727K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| Financing Cash Flow | $2.39M | $463.4M | $10.05M | $623K | -$368K | $218.4M | $234K | $39.97M |
| Net Change in Cash | $16.16M | $3.32M | $33.29M | -$2.84M | -$17.70M | $17.73M | -$22.47M | $23.50M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -22.6% | -28.7% | -29.1% | -- | -- | -49.0% | -- |
| Return on Assets (ROA) | -21.8% | -27.3% | -26.3% | -45.2% | -54.9% | -45.5% | -70.5% |
| Current Ratio | 28.66x | 19.99x | 10.28x | 8.00x | 12.86x | 14.47x | 7.29x |
| Quick Ratio | 27.92x | 19.69x | 9.77x | 7.78x | 12.52x | 14.12x | 6.89x |
| Debt to Equity | 0.00x | -- | 0.00x | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -12.9% | -11.8% | -21.8% | -22.6% | -20.4% | -20.5% | -32.9% | -28.7% |
| Return on Assets (ROA) | -12.6% | -11.6% | -21.2% | -21.8% | -19.8% | -19.9% | -31.3% | -27.3% |
| Current Ratio | 45.95x | 64.07x | 40.32x | 28.66x | 32.95x | 32.58x | 21.06x | 19.99x |
| Quick Ratio | 45.42x | 63.22x | 39.38x | 27.92x | 32.60x | 32.25x | 20.73x | 19.69x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -- |